The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
| العنوان: | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
|---|---|
| المؤلفون: | Irene García Cadenas, Fred Falkenburg, Kate Morgan, Hermann Einsele, Fabio Ciceri, Marcel R.M. van den Brink, Emma C. Morris, Jordi Sierra, Franco Locatelli, Natacha Bolaños, H M Mirjam Heemskerk, Arjan A. van de Loosdrecht, Javier Briones, Michael Hudecek, Roch Houot, Michael O'Dwyer |
| المساهمون: | University Hospital of Würzburg, Hospital de la Santa Creu i Sant Pau, IRCCS San Raffaele Scientific Institute [Milan, Italie], Leiden University Medical Center (LUMC), Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), CHU Pontchaillou [Rennes], Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Myeloma Patients Europe, University College of London [London] (UCL), National University of Ireland Maynooth (Maynooth University), Memorial Sloan Kettering Cancer Center (MSKCC), Amsterdam UMC, Einsele, H., Briones, J., Ciceri, F., Cadenas, I. G., Falkenburg, F., Bolanos, N., Heemskerk, H. M. M., Houot, R., Hudecek, M., Locatelli, F., Morgan, K., Morris, E. C., O'Dwyer, M., Sierra, J. G., van den Brink, M., van de Loosdrecht, A. A., Universiteit Leiden, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome] (UNIROMA), IRCCS Ospedale Pediatrico Bambino Gesù [Roma], Weill Medical College of Cornell University [New York], Amsterdam UMC - Amsterdam University Medical Center |
| المصدر: | HemaSphere HemaSphere, Lippincott, Williams & Wilkins, 2021, 5 (10), pp.e642. ⟨10.1097/HS9.0000000000000642⟩ Einsele, H, Briones, J, Ciceri, F, Cadenas, I G, Falkenburg, F, Bolaños, N, Heemskerk, H M M, Houot, R, Hudecek, M, Locatelli, F, Morgan, K, Morris, E C, O’Dwyer, M, Sierra, J G, van den Brink, M & van de Loosdrecht, A A 2021, ' The EHA research Roadmap : Immune-based therapies for hematological malignancies ', HemaSphere . https://doi.org/10.1097/HS9.0000000000000642Test HemaSphere, 2021, 5 (10), pp.e642. ⟨10.1097/HS9.0000000000000642⟩ HemaSphere, Vol 5, Iss 10, p e642 (2021) |
| بيانات النشر: | HAL CCSD, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | medicine.medical_specialty, Platelet disorder, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Clinical science, Hematopoietic stem cell transplantation, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Diseases of the blood and blood-forming organs, Intensive care medicine, IMMUNE THERAPY, 030304 developmental biology, 0303 health sciences, Hematology, business.industry, Normal hematopoiesis, Transfusion medicine, 3. Good health, Blood Disorder, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, European policy, 030220 oncology & carcinogenesis, Perspective, RC633-647.5, business |
| الوصف: | International audience; In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research(1) aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European Hematology Research. the 11 EHA Research Roadmap sections include normal hematopoiesis; malignant lymphoid diseases; malignant myeloid diseases; anemias and related diseases; platelet disorders; blood coagulation and hemostatic disorders; transfusion medicine; infections in hematology; hematopoietic stem cell transplantation; CAR-T and Other cell-based immune therapies; and gene therapy. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| تدمد: | 2572-9241 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fccccf49d2f8978793400b6b304748d2Test https://hal.archives-ouvertes.fr/hal-03367656Test |
| حقوق: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....fccccf49d2f8978793400b6b304748d2 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 25729241 |
|---|